IMA950
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for IMA950, covering 2014-05-19 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma [Phase 1, Phase 2]